N
Nataliya Petinati
Researcher at Russian Academy
Publications - 26
Citations - 113
Nataliya Petinati is an academic researcher from Russian Academy. The author has contributed to research in topics: Mesenchymal stem cell & Bone marrow. The author has an hindex of 6, co-authored 21 publications receiving 87 citations.
Papers
More filters
Journal ArticleDOI
Analysis of results of acute graft-versus-host disease prophylaxis with donor multipotent mesenchymal stromal cells in patients with hemoblastoses after allogeneic bone marrow transplantation.
Irina N. Shipounova,Nataliya Petinati,Alexey Bigildeev,Ekaterina A. Zezina,Nina Drize,Larisa A. Kuzmina,Elena N. Parovichnikova,Valery G. Savchenko +7 more
TL;DR: It is found that the infusion of MMSC halves the incidence of aGVHD and increases the overall survival of patients and the proposed model of prospective evaluation of the effectiveness of M MSC samples will enable prevention of the development of aJVHD in the maximal number of patients.
Journal ArticleDOI
Proliferative Potential of Multipotent Mesenchymal Stromal Cells from Human Bone Marrow
Oxana A. Zhironkina,Irina N. Shipounova,Alexey Bigildeev,Natalia Sats,Nataliya Petinati,Nina Drize +5 more
TL;DR: C cultured multipotent mesenchymal stromal cells represent a heterogeneous and hierarchically organized population and the characteristics of this population depend of the duration of culturing and age of BM donor.
Journal ArticleDOI
Hematopoiesis during Ontogenesis, Adult Life, and Aging
TL;DR: In the bone marrow of vertebrates, two types of stem cells coexist, i.e., hemopoietic stem cells and mesenchymal stem cells (MSCs).
Journal ArticleDOI
Analysis of multipotent mesenchymal stromal cells used for acute graft-versus-host disease prophylaxis.
Larisa A. Kuzmina,Nataliya Petinati,Irina N. Shipounova,Natalia Sats,Alexey Bigildeev,Ekaterina A. Zezina,Maria D. Popova,Nina J. Drize,Elena N. Parovichnikova,Valery G. Savchenko +9 more
TL;DR: Not all samples of MSCs used for prophylaxis of acute graft‐versus‐host disease (aGvHD) after allogeneic hematopoietic cell transplantation (allo‐HCT) are efficient for aGVHD prevention.
Journal ArticleDOI
Alterations of the bone marrow stromal microenvironment in adult patients with acute myeloid and lymphoblastic leukemias before and after allogeneic hematopoietic stem cell transplantation.
Irina N. Shipounova,Nataliya Petinati,Alexey Bigildeev,Nina J. Drize,Tamara Sorokina,Larisa A. Kuzmina,Elena N. Parovichnikova,Valeri G. Savchenko +7 more
TL;DR: Allo-HSCT conditioning regimens significantly damaged MMSCs and CFU-Fs, and the effect lasted for at least 1 year, but gene expression levels were altered.